Biomedical
sealants have emerged as a promising product for replacing
staples and sutures to prevent liquid and air leakages after and
during surgeries. Surgical sealants are made from synthetic or
natural polymers or a combination of both. Sealant materials are
required to be elastic and compliant with the tissue to allow
movement and function of various tissues of lungs, blood vessel,
skin, and heart. These materials include polyurethane, glycol, and
polyethylene glycol or naturally occurring polysaccharides or
proteins. Polyurethane is used in biomedical sealants due to its
property of strong adhesion and high elasticity to tissues.
Polyethylene glycol in sealants is widely used as hemostatic adhesive
and fluid barrier.
Request
For Sample Copy @
https://www.coherentmarketinsights.com/insight/request-sample/1936
Biomedical
Sealant Market Drivers:-
Approval
of new biomedical sealants in key regions such as Europe is expected
to drive growth of the biomedical sealant market. For instance, in
2017, Starch Medical, marketer and manufacturer of
polysaccharide-based hemostatic products such as biomedical sealants
was approved by C.E. Mark for Super Clot. Post the approval, company
has planned to utilize their existing network of distribution
partners along with their new strategic partners to bring Super Clot
to hospitals and surgical teams throughout Europe. This strategic
planning of product distribution is expected to fuel growth of the
global biomedical sealant market.
Biomedical
Sealant Market Regional Analysis:-
North
America is expected to be dominant in the global biomedical sealant
market over the forecast period. This is due to increasing product
launches by key players in the region. For instance, in 2017, Starch
Medical, a marketer and manufacturer of polysaccharide-based
hemostatic products such as biomedical sealants, launched its new
product Super Clot. Super Clot is a biomedical sealant used for
effective and rapid hemostasis. Such new products in the market are
expected to boost growth of the North America biomedical sealant
market.
Biomedical
Sealant Market Key Players:-
Key
players operating in the global biomedical sealant include Bostik, 3M
Company, Henkel AG & company, KGaA., CryoLife Inc., Chemence
Ltd., Cyberbond LLC., Ethicon Inc., Covidien PLC., Glustitch Inc.,
Adhezion Biomedical LLC., Cohera Medical Inc., Baxter International
Inc., Meyer Haake GmbH, Angiotech Pharmaceuticals Inc., and Biocoral
Inc.
Biomedical
Sealant Market Taxonomy:-
By
Product Type:-
-
Solid
-
Liquid
-
Others
By
Applications:-
-
Vascular surgery
-
Cardiovascular Surgery
-
Gynecology Surgery
-
Urology Surgery
-
Reconstructive and Plastic Surgery
-
Others
Request
For Customization @
https://www.coherentmarketinsights.com/insight/request-customization/1936
About
Coherent Market Insights:
Coherent
Market Insights is a prominent market research and consulting firm
offering action-ready syndicated research reports, custom market
analysis, consulting services, and competitive analysis through
various recommendations related to emerging market trends,
technologies, and potential absolute dollar opportunity.
Contact
Us:
Mr.
Shah
Coherent
Market Insights
1001
4th Ave,
#3200
Seattle,
WA 98154
Tel:
+1-206-701-6702
No comments:
Post a Comment